ATE67666T1 - Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps. - Google Patents

Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.

Info

Publication number
ATE67666T1
ATE67666T1 AT88201047T AT88201047T ATE67666T1 AT E67666 T1 ATE67666 T1 AT E67666T1 AT 88201047 T AT88201047 T AT 88201047T AT 88201047 T AT88201047 T AT 88201047T AT E67666 T1 ATE67666 T1 AT E67666T1
Authority
AT
Austria
Prior art keywords
alzheimer
type
sulfomucopolysaccharids
diseases
therapeutic treatment
Prior art date
Application number
AT88201047T
Other languages
English (en)
Inventor
Umberto Cornelli
Thomas A Ban
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Application granted granted Critical
Publication of ATE67666T1 publication Critical patent/ATE67666T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88201047T 1987-05-28 1988-05-24 Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps. ATE67666T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20698/87A IT1205042B (it) 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
EP88201047A EP0293974B1 (de) 1987-05-28 1988-05-24 Verwendung von Sulfomucopolysacchariden zur therapeutischen Behandlung von Krankheiten des Alzheimertyps

Publications (1)

Publication Number Publication Date
ATE67666T1 true ATE67666T1 (de) 1991-10-15

Family

ID=11170725

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88201047T ATE67666T1 (de) 1987-05-28 1988-05-24 Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.

Country Status (8)

Country Link
US (1) US4956347A (de)
EP (1) EP0293974B1 (de)
JP (1) JPS6419021A (de)
AT (1) ATE67666T1 (de)
DE (1) DE3865099D1 (de)
ES (1) ES2040323T3 (de)
GR (1) GR3002802T3 (de)
IT (1) IT1205042B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486599A (en) 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
US6699968B1 (en) 1989-03-29 2004-03-02 Children's Medical Center Corporation Construction and use of synthetic constructs encoding syndecan
DE58905637D1 (de) * 1989-04-14 1993-10-21 Merz & Co Gmbh & Co Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie.
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
IT1240615B (it) * 1990-04-03 1993-12-17 Mediolanum Farmaceutici Spa Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale
US5164295A (en) * 1991-03-06 1992-11-17 The Upjohn Company Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds
US5958883A (en) * 1992-09-23 1999-09-28 Board Of Regents Of The University Of Washington Office Of Technology Animal models of human amyloidoses
DK1060750T3 (da) * 1993-03-29 2006-01-09 Univ Kingston Propan-1,3-disulfonsyre og dens farmaceutisk acceptable salte til behandling af amyloidose
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US5505948A (en) * 1993-06-01 1996-04-09 Dermatology Home Products, Inc. Home skin peel composition for producing healthy and attractive skin
US6277874B1 (en) * 1996-07-09 2001-08-21 University Of Cincinnati And Apologic, Incorporated Methods for the treatment of apolipoprotein E related diseases
EP1039883A4 (de) * 1996-07-09 2001-09-26 Keith A Crutcher Verfahren zur behandlung apolipoprotein e bedingter krankheiten
CA2301725C (en) * 1997-08-28 2008-11-18 University Of Washington Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
DE60042896D1 (de) * 1999-04-28 2009-10-15 Bellus Health Int Ltd Zusammensetzungen und verfahren zur behandlung von amyloidosis mit sulphonatderivaten
IT1312107B1 (it) 1999-05-14 2002-04-04 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile
US6608042B2 (en) * 2000-03-28 2003-08-19 Aventis Pharma, S.A. Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US20060074049A1 (en) * 2004-10-05 2006-04-06 Mitchell Krathwohl Use of heparinoids for treatment and prevention of dementia
CA2586111A1 (en) * 2004-11-12 2006-06-08 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
WO2006059245A2 (en) * 2004-11-16 2006-06-08 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
US8044100B2 (en) * 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
WO2006111348A1 (de) * 2005-04-18 2006-10-26 Abbott Gmbh & Co. Kg Verwendung von heparin und heparinderivaten zur modulation des neuritenwachstum-kontrollierenden nogo-rezeptors
ES2352801T3 (es) * 2005-12-22 2011-02-23 Kiacta Sàrl Tratamiento de nefropatía diabética.
CA2830727C (en) 2006-10-12 2016-11-29 Bhi Limited Partnership Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
CA2673022A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
WO2015184231A2 (en) * 2014-05-30 2015-12-03 Kolltan Pharmaceuticals, Inc. Regulators of anaplastic lymphoma kinase and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000787A (en) * 1957-11-06 1961-09-19 Crinos Industria Farmaco Heparinoid anticholestrolemic factor
US3007787A (en) * 1960-03-16 1961-11-07 Monsanto Chemicals Butyl xylyl sulfone

Also Published As

Publication number Publication date
US4956347A (en) 1990-09-11
ES2040323T3 (es) 1993-10-16
IT1205042B (it) 1989-03-10
DE3865099D1 (de) 1991-10-31
GR3002802T3 (en) 1993-01-25
EP0293974B1 (de) 1991-09-25
IT8720698A0 (it) 1987-05-28
JPS6419021A (en) 1989-01-23
EP0293974A1 (de) 1988-12-07

Similar Documents

Publication Publication Date Title
ATE67666T1 (de) Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
ATE79544T1 (de) Zusammensetzungen zur behandlung von hypercholesterinaemie.
ATE308336T1 (de) Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
ATE71629T1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
ZW22687A1 (en) Treatment of diseases caused by viruses
ATE99171T1 (de) Praeparate zur behandlung von beschwerden der wurzelhaut der zaehne.
GR861803B (en) Novel carbonic acid derivatives method for their preparation their use and medicine containing them
DE3778585D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
ATE77751T1 (de) Mittel zur behandlung von knochenkrankheiten.
FI864570A0 (fi) Terapeutiskt anvaendbar foerening.
ATE95694T1 (de) Verwendung von bezafibrat zur behandlung von diabetes.
ZA883744B (en) Promotion of healing of meniscal tissue
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ATE59780T1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
DE3875016D1 (de) Therapeutikum zur behandlung von aids.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
DK681288A (da) Aenootropt terapeutisk laegemiddelae
DK639088A (da) Laegemiddel til behandling af iskaemiske hjertesygdomme

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee